| CSL Behring Receives FDA Approval to Extend Shelf Life for Privigen(R) from 24 ... - PR Newswire (press release) |
|
|
PR Newswire (press release)WARNING: Renal dysfunction, acute renal failure, osmotic nephrosis, and death may be associated with the administration of Immune Globulin Intravenous ...CSL Behring Obtains FDA Approval To Extend Shelf Life For Privigen From 24 To ... read more |